en
  • German - de
  • English - en
  • Research Labs
      Binder Lab
        Braun Lab
          Feuchtinger Lab
            Griese Lab
              Hauck Lab
                Hübner Lab
                  Jeremias lab
                    Kim-Hellmuth Lab
                      Klein Lab
                        Kotlarz Lab
                          Lange-Sperandio Lab
                            von Mutius Lab
                              Schaub Lab
                                Schwerd Lab
                                  Schmid Lab
                                • Clinical research
                                    Interdisciplinary pediatric study center (Hauner iPSC)
                                      Ped-COVID-19 Study
                                        Michael Albert
                                          Scivias Study
                                            TRACE Study
                                          • PhD Program
                                          • Technology platforms
                                              Bioinformatics
                                                Flow Cytometry
                                                  High throughput sequencing
                                                    Microscopy
                                                      Pre-GMP Facility
                                                        Mass spectrometry
                                                          Hauner Biobank
                                                        • News/Events
                                                            Meinhard von Pfaundler-Lectures
                                                              Klaus Betke Symposium
                                                            • Join us!
                                                            1. CCRC-HaunerEN
                                                            2. Research Labs
                                                            3. Schmid Lab

                                                            Schmid Lab

                                                            • Group Leader
                                                            • Research
                                                            • Group Members
                                                            • Publications
                                                            • Contact

                                                            Research topics

                                                            • Clinical studies in children with liver tumours
                                                            • miR-492 in hepatoblastoma
                                                            • AHR and DRD5 in AML with MLL-fusion gene

                                                            Prof. Dr. Irene Schmid 

                                                            ✉ Irene.Schmid@med.uni-muenchen.de

                                                            ☎ +49-89-4400-54499 or -57818

                                                            Clinical studies in children with liver tumors 

                                                            Primary childhood liver tumours encompass a range of differing entities whose incidence varies with age. The commonest tumour in young children are hepatoblastomas (43% of all liver tumours) followed by haemangioendotheliomas (13%) and then haemangiomas and mesenchymal hamartomas (6%). In contrast the most frequent type of liver tumour diagnosis in school aged children is hepatocellular carcinomas (HCC, 23%) followed by sarcomas (6%), focal nodular hyperplasia (2%), adenomas (2%) and other tumours (5%). The Registry for Liver Tumours in Children and Adolescents established by our team (1.1.2011) is the first registry to systematically collect informations not only on malignant, but also non-malignant liver tumours in the GPOH catchment area. This information is an invaluable data source for research into areas such as the epidemiology, pathology and therapeutic quality of liver tumour treatment (Health Care Provision Research) for all childhood liver tumours. Currently the PHITT study (Paediatric Hepatic International Tumour Trial) is established for children and adolescents with hepatoblastoma or hepatocellular carcinoma in Germany.

                                                            miR-492 in hepatoblastoma (Dr. rer. nat. Julia von Frowein, Carola Laudano)

                                                            MiR-492 was demonstrated to be significantly upregulated in metastatic HB. Significant correlation of miR-492 levels with the CHIC-stratification system and the 16-gene-signature was also noted. Functionally, miR-492 triggers metastatic progression, perhaps by direct suppression of the cell surface glycoprotein, CD44 (von Frowein et al, Liver Int. 2018; von Frowein et al, Hepatology 2011). Thus, miR-492 has diagnostic, prognostic and therapeutic potential. The current question is, how does miRNA-492 affect the tumour environment thus promoting metastasis of the tumour from the liver to the lungs? The ultimate goal is to create an anti-miR therapy, which can be used in conjugation with conventional chemotherapy. . A further goal is the creation of liquid miRNA-492 biopsies.

                                                            AHR and DRD5 in MLL-rearranged AML (Dr. rer. nat. Katrin Kristina Fleischmann)

                                                            Due to a still unfavorable prognosis, new, targeted therapies are urgently needed for Acute Myeloid Leukemia (AML). An MLL-fusion gene is present in the leukemic cells of a quarter of all children with AML. In preparatory studies, we could prioritize therapeutic targets downstream of the leukemogenic but hard-to-drug MLL-AF9 fusion gene. Two of these, the Aryl Hydrocarbon Receptor (AHR) and the Dopamine Receptor D5 (DRD5), have rarely been studied in the context of leukemia. Besides the recently described roles of AHR (pro-differentiational and anti-proliferative) and DRD5 (proproliferative and prognostic relevance in AML), we could provide evidence of pro-apoptotic and anti-proliferative effects of an AHR agonist and a DRD5 antagonist on leukemic cells with MLL-fusion. This project aims to elucidate the mode of action (signal transduction pathways) as well as the therapeutic efficacy and applicability of the two potential drug targets AHR and DRD5 in the context of AML. Due to the presence of well characterized receptor modulators, a fast transition into the clinic seems within reach.

                                                            Authorship unknown

                                                            Prof. Dr. med. Irene Schmid, Group Leader. Email: irene.schmid@med.uni-muenchen.de. Tel: +49 89 4400 54499

                                                            Dr. rer. nat. Julia von Frowein, Postdoc. Email: julia.frowein@med.uni-muenchen.de. Tel: +49 4400 57818

                                                            Dr. rer. nat. Katrin K. Fleischmann, Postdoc. Email: katrin.fleischmann@med.uni-muenchen.de. Tel: +49 4400 57818

                                                            Carola Laudano, Technician. Email: carola.laudano@med.uni-muenchen.de. Tel: +49 4400 57818

                                                            Selected Publications

                                                            Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P (2017). Lancet Oncol 18, 122-131.

                                                            Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D (2012). Pediatr Blood Cancer 58, 539-544.

                                                            MiR-492 regulates metastatic properties of hepatoblastoma via CD44. Von Frowein J, Hauck SM, Kappler R, Pagel P, Fleischmann KK, Magg T, Cairo S, Roscher A, von Schweinitz D, Schmid I (2018). Liver Int 38, 1280-1291.

                                                            MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. von Frowein J, Pagel P, Kappler R, von Schweinitz D, Roscher A, Schmid I (2011). Hepatology 53, 833-842.

                                                            The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression. Fleischmann KK, Pagel P, von Frowein J, Magg T, Roscher AA, Schmid I (2016). J Exp Clin Cancer Res 13, 35:39.

                                                            RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes. Fleischmann KK, Pagel P, Schmid I, Roscher AA (2014). Mol Cancer 11, 13-27. 

                                                            Complete list of published work: Pubmed

                                                            Irene Schmid Group

                                                            Research Building, KU.07, Lindwurmstr. 2a, 80337 Munich, Germany

                                                            Dr. von Hauner Children`s Hospital, Department for Pediatric Hematology, Oncology, Stem Cell Transplantation, Lindwurmstr. 4, 80337 Munich

                                                            Email: irene.schmid@med.uni-muenchen.de

                                                            Tel. +49 89 4400 54499 or 57818

                                                            Fax. +49 89 4400 57514



                                                            Research at CCRC Hauner

                                                            Contact LMU Klinikum

                                                            Contact CCRC Hauner

                                                            Haunersches

                                                            CCRC Hauner

                                                            Kinderklinik und Kinderpoliklinik

                                                            im Dr. von Haunerschen Kinderspital

                                                            Ludwig Maximilians Universität München

                                                            Lindwurmstr. 4

                                                            80337 Munich, Germany

                                                            ☎ +49-89-4400-57705

                                                            Redakteurs Log-In
                                                            Imprint | Data-Safety
                                                            en
                                                            • German - de
                                                            • English - en

                                                            Comprehensiv...

                                                            • Research Labs
                                                              • Binder Lab
                                                              • Braun Lab
                                                              • Feuchtinger Lab
                                                              • Griese Lab
                                                              • Hauck Lab
                                                              • Hübner Lab
                                                              • Jeremias lab
                                                              • Kim-Hellmuth Lab
                                                              • Klein Lab
                                                              • Kotlarz Lab
                                                              • Lange-Sperandio Lab
                                                              • von Mutius Lab
                                                              • Schaub Lab
                                                              • Schwerd Lab
                                                              • Schmid Lab
                                                            • Clinical research
                                                              • Interdisciplinary pediatric study center (Hauner iPSC)
                                                              • Ped-COVID-19 Study
                                                              • Michael Albert
                                                              • Scivias Study
                                                              • TRACE Study
                                                            • PhD Program
                                                            • Technology platforms
                                                              • Bioinformatics
                                                              • Flow Cytometry
                                                              • High throughput sequencing
                                                              • Microscopy
                                                              • Pre-GMP Facility
                                                              • Mass spectrometry
                                                              • Hauner Biobank
                                                            • News/Events
                                                              • Meinhard von Pfaundler-Lectures
                                                              • Klaus Betke Symposium
                                                            • Join us!